{Reference Type}: Case Reports
{Title}: Challenges in Diagnosis and Treatment of Fasciola hepatica Infection.
{Author}: Pınarlık F;Keske Ş;Rozanes İ;Ergönül Ö;
{Journal}: Infect Dis Clin Microbiol
{Volume}: 5
{Issue}: 1
{Year}: 2023 Mar
暂无{DOI}: 10.36519/idcm.2023.197
{Abstract}: A 57-year-old female patient presented with fever, nausea, vomiting, loss of appetite, and weight loss within the last two months. Ceftriaxone and metronidazole therapy was started upon discovery of a liver abscess but provided no benefit. Following the of abscess biopsy, the patient developed fever, itching, anemia, acute renal failure, hyperbilirubinemia, and eosinophilia that required intensive care unit (ICU) admission. The Fasciola hepatica antibodies were detected by enzyme-linked immunosorbent assay (ELISA). Triclabendazole was started, after which the symptoms and magnetic resonance imaging (MRI) findings regressed. Even without eosinophilia, F. hepatica should be considered in cases with a liver abscess that does not respond to antibiotics.